David Lemus
Director/Board Member chez SCILEX HOLDING COMPANY
Fortune : 31 468 $ au 31/03/2024
Profil
David Lemus is the founder of Lemax LLC.
He currently holds the position of Independent Non-Executive Director at Silence Therapeutics Plc, Director at Pharmaceutical Manufacturers Association of America, Independent Non-Executive Director at Sorrento Therapeutics, Inc., Treasurer & Non-Executive Director at Biohealth Innovation, Inc., Independent Director at Scilex Holding Co., Chief Financial Officer at Ironshore Pharmaceuticals (America), Inc., and Trustee at Mit Club of Washington Dc.
Previously, he served as the Chief Executive Officer at Leadiant Biosciences, Inc., Chief Executive Officer at Ironshore Pharmaceuticals, Inc., Director at Axela, Inc., Independent Director at Scilex, Inc., Treasury Consultant at Electrolux AB, Group Treasurer at Chocoladefabriken Lindt & Sprüngli AG, Chief Operating & Financial Officer at MediGene AG, Chief Financial Officer & Executive Vice President at MorphoSys AG, and Chief Executive & Financial Officer at Medigene, Inc. He also held the position of Chief Operating & Financial Officer at Proteros biostructures GmbH and Manager-Pharma International Division Operations at Hoffman-La Roche, Inc. Mr. Lemus obtained a graduate degree from Massachusetts Institute of Technology, an undergraduate degree from the University of Maryland, and a graduate degree from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SCILEX HOLDING COMPANY
0,01% | 06/03/2023 | 15 625 ( 0,01% ) | 24 844 $ | 31/03/2024 |
SILENCE THERAPEUTICS PLC
0,01% | 01/03/2024 | 7 527 ( 0,01% ) | 6 624 $ | 31/07/2023 |
| 31/01/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Lemus
| Sociétés | Poste | Début |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Director/Board Member | 01/10/2017 |
| SILENCE THERAPEUTICS PLC | Director/Board Member | 21/06/2018 |
| SCILEX HOLDING COMPANY | Director/Board Member | 09/11/2022 |
Ironshore Pharmaceuticals (America), Inc.
 Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | Director of Finance/CFO | - |
| Lemax LLC | Chief Executive Officer | 01/01/2017 |
| Mit Club of Washington Dc | Director/Board Member | - |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Director/Board Member | - |
| Pharmaceutical Manufacturers Association of America | Director/Board Member | - |
Anciens postes connus de David Lemus
| Sociétés | Poste | Fin |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Director/Board Member | 01/11/2022 |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de David Lemus
| Massachusetts Institute of Technology | Graduate Degree |
| University of Maryland | Undergraduate Degree |
| MIT Sloan School of Management | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| ELECTROLUX AB | Consumer Durables |
| LINDT | Consumer Non-Durables |
| MEDIGENE AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| SILENCE THERAPEUTICS PLC | Commercial Services |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 13 |
|---|---|
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Health Services |
| Pharmaceutical Manufacturers Association of America | |
Biohealth Innovation, Inc.
Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Finance |
Ironshore Pharmaceuticals (America), Inc.
Ironshore Pharmaceuticals (America), Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals (America), Inc. manufactures pharmaceutical products. | Health Technology |
| Hoffman-La Roche, Inc. | Health Technology |
| Mit Club of Washington Dc | |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Scilex, Inc. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. The company is headquartered in Paolo Alto, CA. | Health Technology |
| Lemax LLC | |
Ironshore Pharmaceuticals, Inc.
 Ironshore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Ironshore Therapeutics, Inc., Ironshore Pharmaceuticals, Inc. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Morrisville, NC and was founded in 2015. | Health Technology |
| Scilex Holding Co. |
